TipRanks
Citius Oncology (CTOR)
NASDAQ:CTOR
US Market
CTOR
Citius Oncology
RESEARCH TOOLSreports
Want to see CTOR full AI Analyst Report?

Citius Oncology (CTOR) Stock News & Sentiment

134 Followers
Citius Oncology Shareholders Approve Directors and Auditor
Premium
Company Announcements
Citius Oncology Shareholders Approve Directors and Auditor
3d ago
8K
CTOR
Is CTOR a Buy, Before Earnings?
Premium
Pre-Earnings
Is CTOR a Buy, Before Earnings?
2M ago
CTOR
Citius Oncology adds independent director to expanded board
Premium
Company Announcements
Citius Oncology adds independent director to expanded board
2M ago
8K
CTOR
Buy Rating Reaffirmed on Lymphir’s Growing Commercial Momentum and CTCL Market Upside; $4 Price Target Maintained
Premium
Ratings
Buy Rating Reaffirmed on Lymphir’s Growing Commercial Momentum and CTCL Market Upside; $4 Price Target Maintained
2M ago
CTOR
Citius Oncology reports strong LYMPHIR commercial momentum
Premium
Company Announcements
Citius Oncology reports strong LYMPHIR commercial momentum
2M ago
8K
CTOR
Citius Oncology Highlights Promising LYMPHIR Combo Phase 1 Data
Premium
Company Announcements
Citius Oncology Highlights Promising LYMPHIR Combo Phase 1 Data
4M ago
8K
CTOR
Buy Rating Reaffirmed on Lymphir’s Promising Early Data; $4 Price Target Maintained
Premium
Ratings
Buy Rating Reaffirmed on Lymphir’s Promising Early Data; $4 Price Target Maintained
4M ago
CTOR
More CTOR News >

CTOR News on the Web

Citius Oncology Shareholders Approve Directors and Auditor
TipRanks News
Neutral
Armistice Capital Expands Citius Oncology (CTOR) Stake Despite Distress Signals
GuruFocus News
Bullish
Is CTOR a Buy, Before Earnings?
TipRanks News
Bearish
Buy Rating Reaffirmed on Lymphir’s Growing Commercial Momentum and CTCL Market Upside; $4 Price Target Maintained
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Citius Oncology (CTOR)
TipRanks News
Bullish
Citius Oncology registers to sell 32.93M shares of common stock for holders
TipRanks News
Neutral
Buy Rating Reaffirmed on Lymphir’s Promising Early Data; $4 Price Target Maintained
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Roivant Sciences (ROIV) and Citius Oncology (CTOR)
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
CTOR
Sector Average
Media Buzz
This Week1 articles
Weekly Average0 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CTOR’s Media Buzz Sentiment?
Currently, no data Available
What is CTOR’s weekly average amount of articles?
Currently, no data Available
What is CTOR’s News Sentiment?
50% of articles about CTOR were positive this week, compared to its sector average of 91%.
    Healthcare Stocks that are Trending in the News
    HUMHumana
    ACETAdicet Bio
    ZYMEZymeworks
    RHHBYRoche Holding
    QTTBQ32 Bio
    Showing the stocks with the most bullish news sentiment over the past week